Li-Juan Min Selected Research

Type 2 Angiotensin Receptor

1/2019	AT2 receptor stimulation inhibits phosphate-induced vascular calcification.
10/2018	Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation.
3/2018	Roles of angiotensin II type 2 receptor in mice with fetal growth restriction.
1/2018	Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor.
10/2016	Interferon regulatory factor 1 attenuates vascular remodeling; roles of angiotensin II type 2 receptor.
1/2016	Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2 Receptor Agonist on Vascular Remodeling.
8/2014	Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.
3/2014	Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
2/2014	Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.
9/2012	Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Juan Min Research Topics

Disease

16	Cognitive Dysfunction 04/2020 - 07/2006
8	Stroke (Strokes) 10/2018 - 02/2007
8	Vascular Remodeling 10/2016 - 10/2003
6	Insulin Resistance 03/2012 - 05/2004
5	Inflammation (Inflammations) 01/2013 - 10/2009
5	Atherosclerosis 02/2012 - 04/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 10/2008
4	Vascular System Injuries 01/2016 - 10/2003
4	Type 2 Diabetes Mellitus (MODY) 03/2012 - 02/2008
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2011 - 07/2006
3	Brain Injuries (Brain Injury) 10/2018 - 09/2008
3	Hypertension (High Blood Pressure) 01/2017 - 02/2012
3	Neointima 10/2016 - 11/2012
3	Brain Ischemia (Cerebral Ischemia) 09/2011 - 12/2007
2	Dementia (Dementias) 04/2020 - 10/2018
2	Obesity 01/2016 - 01/2013
2	Glucose Intolerance 12/2007 - 12/2006
1	Transient Ischemic Attack 04/2020
1	Vascular Calcification 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 10/2018
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2018
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2018
1	Brain Edema (Cerebral Edema) 08/2014
1	Body Weight (Weight, Body) 07/2014
1	Malnutrition (Nutritional Deficiencies) 09/2012
1	Diabetes Mellitus 05/2012
1	Reperfusion Injury 09/2011
1	Ischemia 09/2008
1	Hyperinsulinism (Hyperinsulinemia) 02/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2007

Drug/Important Bio-Agent (IBA)

17	Angiotensin IIIBA 04/2020 - 10/2003
16	Type 2 Angiotensin ReceptorIBA 01/2019 - 09/2005
7	compound 21IBA 10/2018 - 01/2012
5	Superoxides (Superoxide)IBA 04/2020 - 02/2008
5	PPAR gammaIBA 10/2018 - 10/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 05/2004
5	Insulin (Novolin)FDA Link 01/2013 - 05/2004
5	Telmisartan (Micardis)FDA Link 05/2012 - 10/2008
4	2-chloro-5-nitrobenzanilideIBA 10/2018 - 10/2008
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2009
4	Type 1 Angiotensin ReceptorIBA 03/2014 - 02/2012
4	olmesartanIBA 12/2007 - 04/2005
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 05/2012
3	Polyethylene (Polythene)IBA 01/2016 - 03/2014
3	Messenger RNA (mRNA)IBA 01/2016 - 07/2006
3	Angiotensin II Type 1 Receptor BlockersIBA 05/2012 - 12/2006
3	Valsartan (Vals)FDA Link 07/2006 - 05/2004
3	ApolipoproteinsIBA 09/2005 - 04/2005
2	NADP (NADPH)IBA 04/2020 - 10/2018
2	Amyloid (Amyloid Fibrils)IBA 04/2020 - 02/2012
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 10/2018 - 10/2016
2	Angiotensin-Converting Enzyme 2IBA 01/2018 - 03/2014
2	AngiotensinsIBA 01/2018 - 01/2016
2	EnzymesIBA 01/2018 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 10/2003
2	CytokinesIBA 01/2017 - 01/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016 - 11/2012
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2016 - 11/2012
2	propagermanium (Ge 132)IBA 11/2012 - 06/2011
2	Losartan (Cozaar)FDA LinkGeneric 08/2010 - 10/2008
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2008 - 12/2006
2	Angiotensin Receptor AntagonistsIBA 12/2007 - 12/2006
2	azelnidipineIBA 12/2006 - 07/2005
1	neutrophil cytosol factor 40KIBA 04/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2020
1	Receptor for Advanced Glycation End ProductsIBA 04/2020
1	Monocyte Chemoattractant ProteinsIBA 04/2020
1	InterleukinsIBA 04/2020
1	Phosphates (Orthophosphate)IBA 01/2019
1	Adenine FDA LinkGeneric 01/2019
1	Interferon Regulatory FactorsIBA 10/2018
1	Superoxide DismutaseIBA 10/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Caseins (Casein)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	LipidsIBA 01/2016
1	NAD (NADH)IBA 01/2016
1	azilsartanIBA 07/2014
1	angiotensin I (1-7)IBA 03/2014
1	Memantine (Namenda)FDA Link 02/2014
1	Irbesartan FDA LinkGeneric 11/2012
1	Dietary ProteinsIBA 09/2012
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2012
1	Interleukin-17 (Interleukin 17)IBA 02/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2010
1	Amyloid beta-PeptidesIBA 10/2009
1	Nifedipine (Adalat)FDA LinkGeneric 02/2008
1	SaltsIBA 12/2007
1	Methyl MethanesulfonateIBA 12/2007
1	candesartanIBA 12/2007
1	CholesterolIBA 12/2007
1	Eplerenone (Inspra)FDA LinkGeneric 07/2007
1	Small Interfering RNA (siRNA)IBA 07/2006
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 09/2005

Therapy/Procedure

2	Oral Administration 01/2017 - 12/2007
1	Transplantation 01/2013
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2011
1	Lasers (Laser) 07/2007